HOME › DRUGS › SITAGLIPTIN;METFORMIN
ACTIVE SUBSTANCE / INN

SITAGLIPTIN;METFORMIN

Brand name(s): Janumet, Efficib, Velmetia
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Sitagliptin;Metformin
REGULATORS
EMA
SPONSORS / MAH
Merck Sharp & Dohme B.V., Merck Sharp and Dohme B.V
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VelmetiaMerck Sharp & Dohme B.V.Authorised16/07/2008Diabetes Mellitus, Type 2
EfficibMerck Sharp and Dohme B.VAuthorised15/07/2008Diabetes Mellitus, Type 2
JanumetMerck Sharp & Dohme B.V.Authorised16/07/2008Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON SITAGLIPTIN;METFORMIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →